The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase I study of ALT-P7, a HER2-targeting antibody-drug conjugate in patients with HER2-positive advanced breast cancer.
 
Yeon Hee Park
Honoraria - Merck; Novartis; Pfizer
Consulting or Advisory Role - Pfizer
Research Funding - AstraZeneca; Eisai; Pfizer
Travel, Accommodations, Expenses - Merck; Novartis
 
Hee Kyung Ahn
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Lilly; MSD; Roche
Research Funding - Samyan Biopharm
 
Ji-Yeon Kim
No Relationships to Disclose
 
Jin Seok Ahn
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb-Ono Pharmaceutical; Eisai; Janssen; Menarini; MSD; Pfizer; Roche
Consulting or Advisory Role - Samsung Bioepis
 
Young-Hyuck Im
No Relationships to Disclose
 
Seol-Hee Kim
Employment - Alteogen
Patents, Royalties, Other Intellectual Property - antibody-drug conjugate (Inst)
 
Sunbae Lee
Employment - Alteogen
Stock and Other Ownership Interests - Alteogen
Patents, Royalties, Other Intellectual Property - Alteogen
 
HYE-SHIN CHUNG
Employment - Alteogen
Stock and Other Ownership Interests - Alteogen
Patents, Royalties, Other Intellectual Property - Alteogen
 
Soon Jae Park
Employment - Alteogen
Leadership - Alteogen
Stock and Other Ownership Interests - Alteogen
Patents, Royalties, Other Intellectual Property - Alteogen